Home

(Reuters) - TearLab Corp said health regulators allowed home use of its device to diagnose dry eye condition, sending the medical device maker's shares up as much as 80 percent to their highest in eight months.

The U.S. Food and Drug Administration granted Clinical Laboratory Improvement Amendments (CLlA) waiver to the company's TearLab Osmolarity System, based on a ...

LONDON (Reuters) - Novartis's costly eye drug Lucentis has been rejected for another new use by Britain's health cost-effectiveness watchdog NICE, following a similar setback in July.

The National Institute for Health and Clinical Excellence (NICE) said on Thursday its preliminary recommendation was against using Lucentis for visual impairment caused by macular oedema secondary to central or branch retinal ...

A special lottery launched by a Spanish charity for the blind to mark the 11th day of the 11th month of 2011 cleaned up with all of its 13.5 million tickets sold, organisers said Friday.

Long queues formed at lottery stands run by ONCE, a charity for the blind whose name means "eleven" in Spanish, in the hope that ...

A former Sudanese slave blinded by a cruel master pleaded for help Tuesday in throwing the spotlight on the plight of others like him, and to find his missing mother.

Ker Aleu Deng was a victim of the 22-year civil war between Sudan's northern and southern regions that ended in 2005 after claiming two million lives and displacing four ...

ALBANY, New York (Reuters) - New Yorkers will no longer be required to take an eye test to renew their driver's licenses under a rule change that takes effect on Wednesday.

State Department of Motor Vehicles Commissioner Barbara Fiala said her agency will allow customers to "self-certify" that they meet the driving vision requirement.

New York joins six other states ...

(Reuters) - The U.S. Department of Veterans Affairs said it has stopped using Roche's Avastin to treat a sight-robbing eye disease as it looks into reports of increased risk of infection.

Roche's Lucentis is specifically approved to treat wet age-related macular degeneration -- the leading cause of blindness in the elderly. But its multibillion-dollar a year cancer drug Avastin ...

NEW YORK (Reuters Health) - A school-based program aimed at getting more Chinese teenagers with vision problems to buy glasses has failed, according to a new report.

The finding is a set-back for researchers working to improve visual health in a country where "nearly half of all vision impairment among children in the world" occurs, researchers write.

"It's tough, because ...

NEW YORK (Reuters Health) - Astronauts experience bone and muscle loss in the weightlessness of space, and now the first study of returning space travelers' eyes suggests that prolonged amounts of time in orbit can take a significant toll on vision, although the long-term effects aren't clear.

The new study, of more than 300 astronauts in the U.S. space ...

LOS ANGELES (Reuters) - Five patients being treated for eye disease were blinded after being injected with Roche Holding AG's Avastin at the Los Angeles Veterans Affairs medical center, according to the New York Times.

VA officials did not respond to requests for comment.

The latest cases of blindness follow an alert from the U.S. Food and Drug Administration ...

CHICAGO (Reuters) - Repackaged injections of the cancer drug Avastin, also known as bevacizumab, have caused a cluster of serious eye infections in the Miami, Florida area, the U.S. Food and Drug Administration said on Wednesday.

The Florida Department of Health notified the FDA of Streptococcus endophthalmitis infections in three clinics following injections given through the eye of repackaged Avastin ...